loading

Finanzdaten der Fulcrum Therapeutics Inc-Aktie (FULC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 80.00
Operating Expenses
2.88%
19.82
20.40 19.43 25.13 27.51
Operating Income/Loss
2.88%
-19.82
-20.40 -19.43 -25.13 52.49
Income/Loss From Continuing Operations Before Tax
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Income/Loss From Continuing Operations After Tax
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Net Income/Loss
2.03%
-17.30
-17.66 -16.57 -21.70 55.41
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
62.54
62.48 -62.14 62.41 62.20
Diluted Average Shares
0.10%
62.54
62.48 -63.63 62.41 63.59
Basic Earnings Per Share
0.00%
-0.28
-0.28 -0.27 -0.35 0.89
Diluted Earnings Per Share
0.00%
-0.28
-0.28 -0.27 -0.35 0.87
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.79
price up icon 1.04%
$84.86
price up icon 1.02%
$24.82
price down icon 7.76%
$102.07
price down icon 2.60%
$133.58
price up icon 1.10%
biotechnology ONC
$299.02
price down icon 3.31%
Kapitalisierung:     |  Volumen (24h):